Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30747957.
- Also identified by DOI 10.1001/jama.2018.20391 and PMC identifier 6439585.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses Medicare Part D prescription drug plan formulary files to characterize changes in coverage of buprenorphine and buprenorphine-naloxone for opioid use disorder in 2007, 2012, and 2018.
Medical subject headings
- Buprenorphine
- Insurance Coverage
- Medicare Part D